Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
I base my "gut feeling" on reviewing clinical trial results where all seem to do well except lower success results for non responders.
Triple therapy with IFN seemed to help relapsers but not non/null responders (TT?).
This seems apparent in Sofosbuvir trials that include IFN as well.
Marilyn,, we all have to make our own decisions on the treatment mix. We can be taken under advice but the bottom line is nobody will make any guarantees on treatment outcomes, either success or collateral damage from the drugs. Perhaps your hesitation is your inner voice telling you to wait. It has to be your decision, it's a gamble, you may win or or not. I wish you strength throughout the process.
continue with discussion-